BEST UNLIMITED TURBO LONG CERTIFICATE - FRESENIUS Stock

Certificat

EN98S

DE000SQ4TXV9

Market Closed - Euronext Paris 12:30:01 2024-05-08 pm EDT
3.356 EUR +4.00% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - FRESENIUS
Current month+8.78%
1 month+65.56%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-08 3.356 +4.00% 114
24-05-07 3.227 +4.40% 107
24-05-06 3.091 -2.15% 111
24-05-03 3.159 -1.92% 115
24-05-02 3.221 +4.41% 119

Real-time Euronext Paris

Last update May 08, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
EN98S
ISINDE000SQ4TXV9
Date issued 2022-11-23
Strike 21.89
Maturity Unlimited
Parity 2 : 1
Emission price 2.37
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.34
Lowest since issue 1.417

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.48 EUR
Average target price
36.28 EUR
Spread / Average Target
+27.39%
Consensus
  1. Stock Market
  2. Certificates
  3. EN98S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW